Update December 2014

Market Analysis and Business Strategy

Business Development

Regulatory Affairs and Clinical Trials Management

Reimbursement and Contracting Strategies

Financing Support

Welcome to Boston MedTech Advisors

Included in this issue...

Please call us at 781.407.0900 if you have any questions about the information in this newsletter or if you would like to discuss our services.

Boston MedTech Advisors 10th Anniversary

This year Boston MedTech Advisors marked its 10th year of operations.  During these years BMTA has worked with over 150 companies, representing the cross section of medical technology innovation worldwide.  Our clients span the globe - US, Europe, Israel and the Far East - and the diversity of medical disciplines and specialties. We worked with entrepreneurs, VC-backed companies, companies that have gone public as well as large, well-established organizations exploring new strategic opportunities. Our activities have addressed a broad range of challenges, including helping companies to obtain regulatory approvals, managing complex clinical studies, assessing market and business strategies, supporting business development initiatives, navigating the complex and ever changing reimbursement and health economic challenges, and assisting their fund raising campaigns. Throughout all our activities we have been focused on helping the companies to realize clinical adoption for their new technologies and procedures, while increasing shareholder returns. We are especially gratified for the numerous personal relationships that were developed during these years. 

BMTA Holds its 2nd Annual Seminar in Tel Aviv, December 17, 2014

BMTA hosted its 2nd annual seminar in Tel Aviv, Israel on December 17, 2014. The title of this year's meeting "The Brave New World of Medical Devices" highlights the changes occurring in the industry and some of the implications and proposed strategies that developers of medical technologies should embrace in order to succeed in this new environment.

The topics should be of interest to senior executives, board members and investors in medtech companies: "Clinical Evidence - 510(k) and Beyond", discussed by Zvi Ladin, PhD and the provocative "It's All About the Adoption" - More Than a Mantra, by David Barone.  Click here to view the presentation.

Dr. Michael Imhoff Speaks at Clinical Alarm Safety Symposium

Michael Imhoff, MD, PhD, Sr. Advisor of BMTA, was an invited speaker at the Clinical Alarm Safety Symposium in Washington D.C. on November 21, 2014.  Dr. Imhoff discussed clinical risk management related to in-hospital alarms, an area of great significance to all manufacturers of instruments incorporating alarms and smart alerts.

BMTA Supported Massachusetts Innovation Partnership Mission to Israel

  • David Barone, Principal of BMTA, joined Commonwealth of Massachusetts Governor Deval Patrick this spring in his Innovation Partnership Mission, which also included the CEOs of Massachusetts General Hospital and Beth Israel Deaconess Medical Center, and over 100 additional executives representing the best of MA industry, research, investment, academia and government. The visit to Israel included a private meeting organized by David, between 8 CEOs of medical technology companies, each with existing presence in MA, and the Governor and key members of his administration, as well as the leading healthcare executives in the delegation.
  • During the delegation visit David has also joined a panel discussing "Medical Devices / Getting to Market Adoption", sponsored by the Massachusetts Life Science Center. Other panelists included Dr. Peter Slavin, President of MGH, Efi Cohen-Arazi, CEO of Rainbow Medical, and Robert Urban, Head of J&J Innovation Center.

Dr. Gary Gottlieb, CEO of Partners Healthcare Meets with Israeli MedTech Executives

David, who serves as the Chairman of the Life Sciences Committee of the New England - Israel Business Council, joined Dr. Gary Gottlieb, CEO of Partners Healthcare, during his recent visit to Israel, and for his keynote presentations at the IATI/Biomed Annual Conference and at the NEIBC Life Sciences Annual Reception in Tel Aviv. Over 30 CEOs, directors and investors representing a cross section of the medical industry, including many companies working with BMTA, have met with Dr. Gottlieb during the visit, describing their stories and exploring ideas for expanded collaboration with Partners, the largest healthcare provider in New England.

Neuroscience World Medical Innovation Forum

Boston Med Tech Advisors is pleased to partner with the Neuroscience World Medical Innovation Forum, taking place April 27-29, 2015 in Boston, MA.  The Forum is organized by Partners HealthCare, the parent organization of the world-renown Brigham and Women's, Massachusetts General and McLean Hospitals. Attendees from around the world will convene to meet, engage and hear the keynote speakers, including Robert Bradway, CEO, Amgen; Jeff Immelt, CEO, General Electric; Joe Jimenez, CEO, Novartis; Mike Mahoney, CEO, Boston Scientific; and George Scangos, CEO, Biogen Idec, as well as dozens of CEOs of neuroscience focused companies discussing their breakthrough technologies. To learn more about the World Medical Innovation Forum and to register visit http://worldmedicalinnovation.org.  A reduced registration rate is available until January 1, 2015. Contact BMTA before registering for the conference to receive an additional 10% discount. 

New BMTA Hires

We welcomed three Senior Consultants to Boston MedTech Advisors this year:

  • Denise Clarke has 15 years experience in clinical research and development of new medical devices, market analysis and clinical trial management.  Denise is a certified Clinical Research Associate and the current President of the New England Chapter, Association of Clinical Research Professionals. Prior to her recent graduation from the MBA / Healthcare Sector program from Boston University, Denise worked for Philips Healthcare.
  • Tom Keegan rejoined BMTA earlier this year after serving for a year as Vice President for Business Development and US Marketing for one of BMTA's portfolio companies. Tom has over 20 years of marketing, technical and clinical experience in the medical device industry, including minimally invasive surgery, orthopedic and spine. Prior to joining BMTA Tom served as the Vice President Marketing - MIS Solutions for Zimmer Spine.
  • Zohar Zephrani, PhD has extensive research background in neuroscience, cognition, sensation and perception, managing large-scale projects in the fields of neural-based human behavior and advanced imaging technology. Her current activities focus on regulatory submissions and clinical, scientific and market research. Prior to joining BMTA, Zohar ran research programs at Columbia University in NY and Brown University in RI.

About Boston MedTech Advisors

Boston MedTech Advisors is a medical device consulting and professional services company with a presence in the U.S., Europe and Israel, focusing on the acceleration of market adoption of new medical technologies. We support our clients in the commercialization of new products and services by addressing the highly interdependent regulatory, clinical development, reimbursement, marketing and business development requirements of the global medical technology industry.

email logo
Boston MedTech Advisors
US: 781-407-0900  |  Germany: +49-231-973022-10